114 related articles for article (PubMed ID: 21883470)
1. The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation.
Spargias K; Polymeros S; Dimopoulos A; Manginas A; Pavlides G; Balanika M; Smirli A; Stavridis G; Dangas G; Cokkinos DV
J Interv Cardiol; 2011 Oct; 24(5):462-9. PubMed ID: 21883470
[TBL] [Abstract][Full Text] [Related]
2. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
5. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
6. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M
J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090
[TBL] [Abstract][Full Text] [Related]
7. Preoperative, postoperative and one-year follow-up of N-terminal pro-B-type natriuretic peptide levels in volume overload of aortic regurgitation: comparison with pressure overload of aortic stenosis.
Song BG; Park YH; Kang GH; Chun WJ; Oh JH; Choi JO; Lee SC; Park SW; Oh JK; Sung KI; Park P; Jeon ES
Cardiology; 2010; 116(4):286-91. PubMed ID: 20861629
[TBL] [Abstract][Full Text] [Related]
8. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
[TBL] [Abstract][Full Text] [Related]
9. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
[TBL] [Abstract][Full Text] [Related]
10. NT-pro-brain natriuretic peptide levels after valve replacement.
Elasfar AA
Asian Cardiovasc Thorac Ann; 2011 Dec; 19(6):399-402. PubMed ID: 22160408
[TBL] [Abstract][Full Text] [Related]
11. Baseline NT-proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation.
Allen CJ; Joseph J; Patterson T; Hammond-Haley M; McConkey HZR; Prendergast BD; Marber M; Redwood SR
J Am Heart Assoc; 2020 Dec; 9(23):e017574. PubMed ID: 33241754
[TBL] [Abstract][Full Text] [Related]
12. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
[TBL] [Abstract][Full Text] [Related]
13. Does residual aortic regurgitation after transcatheter aortic valve implantation increase mortality in all patients? The importance of baseline natriuretic peptides.
Borz B; Durand E; Godin M; Tron C; Canville A; Hauville C; Bauer F; Cribier A; Eltchaninoff H
Int J Cardiol; 2014 May; 173(3):436-40. PubMed ID: 24679693
[TBL] [Abstract][Full Text] [Related]
14. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
[TBL] [Abstract][Full Text] [Related]
15. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.
Schewel D; Frerker C; Schewel J; Wohlmuth P; Meincke F; Thielsen T; Kreidel F; Kuck KH; Schäfer U
Catheter Cardiovasc Interv; 2015 Feb; 85(3):502-14. PubMed ID: 24259366
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.
Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C
Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919
[TBL] [Abstract][Full Text] [Related]
18. NT-proBNP in the mitral valve surgery.
Perreas K; Samanidis G; Dimitriou S; Athanasiou A; Balanika M; Smirli A; Antzaka C; Politis K; Khoury M; Michalis A
Crit Pathw Cardiol; 2014 Jun; 13(2):55-61. PubMed ID: 24827881
[TBL] [Abstract][Full Text] [Related]
19. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.
Weber M; Arnold R; Rau M; Elsaesser A; Brandt R; Mitrovic V; Hamm C
Eur Heart J; 2005 May; 26(10):1023-30. PubMed ID: 15781428
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
